Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009 - Wikidata - wikimedia - TriplyDB

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009

http://www.wikidata.org/entity/Q37347327

about

Hepatobiliary Tumors: Update on Diagnosis and Management Cholangiocarcinoma and malignant bile duct obstruction: A review of last decades advances in therapeutic endoscopy Imaging and interventions in hilar cholangiocarcinoma: A review Systematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancer MicroRNAs and benign biliary tract diseases Progression of targeted therapy in advanced cholangiocarcinoma Endoscopic versus Percutaneous Biliary Drainage in Palliation of Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic Review Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma.Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in Intrahepatic Cholangiocellular Carcinoma (ICC): Results from a National Multi-Center Study on Safety and Efficacy Upregulated long noncoding RNA PANDAR predicts an unfavorable prognosis and promotes tumorigenesis in cholangiocarcinoma Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes.MicroRNAs in Cholangiopathies.Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors Prototype of biliary drug-eluting stent with photodynamic and chemotherapy using electrospinning.Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection : Analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation.Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor New insights on cholangiocarcinoma.Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival.Surgical strategy for bile duct cancer: Advances and current limitations.Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma Imaging of malignancies of the biliary tract- an update.Triptolide and TRAIL combination enhances apoptosis in cholangiocarcinoma Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic radiotherapy.Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma.Dilated biliary system. Type-1A choledochal cyst with cholalgocarcinoma.Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis.Mutual regulation between microRNA-373 and methyl-CpG-binding domain protein 2 in hilar cholangiocarcinoma.Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma.The Ser326Cys polymorphism of hOGG1 is associated with intrahepatic cholangiocarcinoma susceptibility in a Chinese population.Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival.Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy.Oncogenic activity of retinoic acid receptor γ is exhibited through activation of the Akt/NF-κB and Wnt/β-catenin pathways in cholangiocarcinoma.Targeted therapy for biliary tract cancer.Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations.

P2860

Q26775654-A35DF58B-A682-4200-8C8D-AC112948FF04 Q26823868-FF822D32-C004-4B8D-B69F-6338760EB109 Q26823900-BA5DD21F-A921-45B0-8BB9-D2E8ACB46CB2 Q26864932-3F098A8E-AB08-480B-ACDC-594C7712CCDE Q26865762-56F3E82D-EA87-4E5C-B505-64355D0E6756 Q27016150-12FC728B-2DBF-4318-85C0-2BFEF0B5E054 Q28075370-8728533E-AA09-41C6-BD39-AAD4E086B7B2 Q33390747-04CDC7C7-2CC5-4E61-87CE-F5E097057D89 Q33411061-01E9FB70-978B-428B-900A-0D7A3C2478A5 Q33439286-BC9964F5-F5E2-44A1-BE36-F1E8A806CF59 Q33813109-4F61EC53-89A2-42F1-9600-E46FD72FF305 Q33909909-9A9B2689-B080-494F-894F-0F9D5E8FD3CA Q33991899-264E7F26-32BD-48FF-960F-B73DF84DFE62 Q33999840-08E971D4-C0AB-424F-9695-545FA927CE44 Q34104493-80D1F1AB-9A24-4C21-A0E2-C0D058644117 Q34136213-8135B3B7-26BF-4F3E-906F-71545AD06B95 Q34242523-EDB18357-3EBC-4DBA-8ED7-8331732E18C2 Q34265846-C8C191F3-9434-4C28-9016-BD5D9C2A5F02 Q34391135-681CCC13-45E3-411A-B9CD-5B9997FE33F6 Q34623728-EDF9EF43-5D26-4FC9-962B-92F0EAE64680 Q34629377-642ABB03-A08E-4F36-BA54-EFBAA0D4834A Q34654186-9519F3F2-8A97-42AC-959F-3EC78FB23AD7 Q35039581-60C59582-D062-4981-8ACC-E756D95060C8 Q35093239-065DF79C-0425-4C3A-AF10-8CDD96F5B591 Q35150435-969B099C-3566-4235-8054-0E6ECB758F2F Q35629462-D40C2536-E9A8-420E-968E-1FD31DA03F44 Q35675390-7C9C3F02-D94A-470C-B064-9EBBF3AC0887 Q35766425-F9E90914-E6BA-460B-8230-31DF186B84F5 Q35934826-A1FFFE26-D2DA-4E8B-945A-99BAEA5B2BF8 Q35959699-08209FF1-8F86-4731-B199-A51A33D3EAA4 Q36020948-AAF4B56D-861E-4AE5-882B-1E1CF719AEE0 Q36120982-02789C4B-67A8-4D6B-8944-09147F820D5A Q36144491-433146DA-A5AD-474D-B5C8-C4E44FA241E3 Q36190116-EB0C7FBF-0AFE-4DA7-B8AA-C9F68E437661 Q36317944-BD481C89-F34A-4767-AD18-AB8A292F264D Q36352012-7998B239-6BAC-4250-BBFD-7B3E0E363F93 Q36828560-C1344EB3-EA84-410E-AA44-C62772C16804 Q37122721-0A132E54-FCF9-4C50-A6D5-ED4C3A6C7E32 Q37132750-359A1D44-671A-4127-B743-EB4D9FB7A437 Q37269146-155AEE3F-8E85-45B4-950C-2717AAF34757

P2860

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009

http://www.wikidata.org/entity/Q37347327

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009

@en

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

@nl

type

label

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009

@en

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

@nl

prefLabel

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009

@en

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

@nl

P1433

Q37347327-F18F20FC-C7D9-4188-92B5-2A779D86B624

P1476

Q37347327-87453B9E-A992-463B-9E60-7D7541C6FFBE

P2093

Q37347327-605D0098-DE75-4A13-BA5C-51C7A510668C

Q37347327-9AC1AB7A-E78A-4E90-9F96-A882D2DA549D

Q37347327-F7FC898A-D1C4-4DDF-9F79-05E6471FF147

P2860

Q37347327-02CD92DC-921B-400D-B79F-C01E7207418E

Q37347327-032C2BB7-1254-4751-B898-2238834F84EA

Q37347327-0680DA92-2B04-4E83-AE1E-937978B120D1

Q37347327-085651CA-45BA-4768-B69F-A9137322DBC9

Q37347327-09B722DB-0449-4AD5-9B49-24BF9EDBBFF1

Q37347327-0C9F0B5B-AFF5-4930-BA1D-38DC24BFF4AB

Q37347327-1035E233-56DF-4541-81B8-44A001C4BDDC

Q37347327-131BE6C5-10ED-409A-8D4D-4785A8F16B73

Q37347327-13AFA515-5E17-4DEA-8825-CEBEA4C818C0

Q37347327-146B784B-4E17-43A8-A303-1441C919580F

P304

Q37347327-304047C9-B8F5-4982-A15B-8295CE0DC980

P31

Q37347327-D67A6237-36D4-4EEE-852D-51D7A6EF5097

P356

Q37347327-165624F1-2929-4A03-8724-694850DE8F09

P407

Q37347327-88A09EBD-C044-47F2-A0BA-6E260084781D

P433

Q37347327-13A28C20-01F6-4E8A-B37E-F163175FE20A

P478

Q37347327-1A186A60-6948-426D-9FEA-0CFEAAFAAD5F

P577

Q37347327-FD743930-C4E3-4843-BA65-CD3DE5E3E83F

P698

Q37347327-B84F7539-63B0-42CE-AED0-0F95856098B6

P921

Q37347327-F3837B24-613C-4D9A-95A4-8B6D0CF73999

Q37347327-b5307287-160a-423d-8af3-01db7e3e3875

P932

Q37347327-E8961A99-2BEE-4859-A682-DF0732EA91C8

P356

P1433

World Journal of Gastroenterology

P1476

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009

@en

P2093

Mark J Walsh

http://www.w3.org/2001/XMLSchema#string

Michele Molinari

http://www.w3.org/2001/XMLSchema#string

Murad Aljiffry

http://www.w3.org/2001/XMLSchema#string

P2860

Worldwide trends in mortality from biliary tract malignancies.

Choledochal cyst disease. A changing pattern of presentation

Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival

Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

Cholangiocarcinoma complicating primary sclerosing cholangitis

Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions

Isoniazid and bile duct cancer

Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival.

P304

4240-4262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.15.4240

http://www.w3.org/2001/XMLSchema#string

P407

P433

34

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19750567

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

2744180

http://www.w3.org/2001/XMLSchema#string